Scientists can now watch lipids in action inside living cells, thanks to a new high-throughput tool called the CLiB assay. Developed by University of Osaka researchers, it rapidly screens thousands of protein variants to find the best lipid-binding sensors. The technology could unlock new insights into cancer, diabetes, and neurodegenerative diseases.
Lipid molecules are essential players inside every cell — they form membranes, help organelles communicate, and respond to stress. But studying them in real time has been nearly impossible due to a lack of sensitive, selective detection tools. That bottleneck may now be broken.
Researchers at the University of Osaka have developed the Cell surface Liposome Binding (CLiB) assay, a high-throughput method published in Nature Cell Biology that uses yeast cells, liposomes, and fluorescence readouts to screen thousands of protein variants for lipid-binding ability. Using this tool, the team engineered a new probe — PX-SnxAGV — capable of detecting PI(3,5)P2, a rare signaling lipid previously too scarce to track reliably. The probe revealed that under stress conditions, PI(3,5)P2 clusters in distinct membrane regions — and during cellular "self-cleaning" (microautophagy), it concentrates at sites where membranes fold inward to engulf damaged material.
Key Takeaways:
Why it matters: Better lipid-tracking tools could open new doors for understanding — and ultimately treating — a wide range of diseases where cell membrane biology goes wrong.
